Trastuzumab Deruxtecan for Human Epidermal Growth Factor Receptor 2-Low Breast Cancer With Cancer-Related Microangiopathic Hemolytic Anemia:A Case ReportOA
Trastuzumab Deruxtecan for Human Epidermal Growth Factor Receptor 2-Low Breast Cancer With Cancer-Related Microangiopathic Hemolytic Anemia:A Case Report
Mengyuan Li;Mao Ding;Yukun Hou;Xuening Duan;Yuanjia Cheng;Ling Xu
Department of Thyroid and Breast Surgery,Peking University First Hospital,Beijing,ChinaDepartment of Thyroid and Breast Surgery,Peking University First Hospital,Beijing,ChinaDepartment of Thyroid and Breast Surgery,Peking University First Hospital,Beijing,ChinaDepartment of Thyroid and Breast Surgery,Peking University First Hospital,Beijing,ChinaDepartment of Thyroid and Breast Surgery,Peking University First Hospital,Beijing,ChinaDepartment of Thyroid and Breast Surgery,Peking University First Hospital,Beijing,China
breast cancerHER2-lowmicroangiopathic hemolytic anemiatrastuzumab deruxtecan
breast cancerHER2-lowmicroangiopathic hemolytic anemiatrastuzumab deruxtecan
《肿瘤学创新(英文)》 2025 (5)
92-96,5
评论